Orthopedic Companies Spot Opportunity in Ambulatory Settings Market Drivers Forward-thinking orthopedic and spine companies seek to predict and capitalize on the movement of procedures to ambulatory facilities. Jan 18, 2022
VUZE Medical Gains FDA 510(k) for Spinal Surgery Software Robotics/Tech Real-time image processing enables software-only guidance and verification in minimally invasive spine surgery. Jan 18, 2022
Orthopedic Sales Unlikely to See Upside in 4Q Earnings Results Market Analysis The orthopedic market finds itself in familiar territory in early 2022, with record COVID cases impacting elective surgery volumes. Jan 10, 2022
What Orthopedic Companies Need to Know about Hospital Supply Chains Executive Insights The dust is starting to settle about what may be long-term in the orthopedic manufacturer-to-hospital supply chain and what may have been an anomaly. Dec 13, 2021
Stryker’s Return to Orthopedics’ Top Spot Years in the Making Market Analysis Stryker and DePuy Synthes have grappled for the top spot in orthopedic sales for decades. We project that Stryker will reclaim the lead in 2021. Dec 13, 2021
Medtronic Spine Growth Stymied by COVID Headwinds Company Revenue The company grew in the low single digits as enabling technology sales and strength in emerging markets helped offset COVID declines. Nov 29, 2021
Vericel Expects Record MACI Sales to End 2021 Company Revenue The company's MACI product declined in the low single digits for 3Q21 but Vericel expects a record-setting fourth quarter. Nov 17, 2021
DJO Outperforms Market Amid COVID Spike Company Revenue The company grew in the high single digits in 3Q21, led by shoulder implant sales and recent acquisitions. Nov 16, 2021
Treace Medical Concepts Outperforms Expectations in Third Quarter Company Revenue The company grew more than +51% in 3Q21, driven by an expanding active surgeon base and increased utlization per surgeon. Nov 15, 2021
OrthoPediatrics Grows on Strength of International Sales Company Revenue The company grew in the double digits for 3Q21, aided by strong international sales in European and South American markets. Nov 12, 2021